CBO Report Requested by GOP Congressional Committee Chairs Links 340B Growth to Drug Spending Trends, ACA-Related Changes and Contract Pharmacy Use Expansion

The new Congressional Budget Office report looked at growth in the 340B program between 2010 and 2021.
340B covered entities in the prime vendor program (PVP) spent nearly $44 billion on 340B drugs in 2021—up from $6.6 [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Hospital Group Asks FTC, DOJ to Investigate Drugmakers’ Potential ‘Anticompetitive’ Efforts to Impose 340B Rebate Models

The AHA asked federal officials Monday to investigate whether five drugmakers engaged in anticompetitive practices while seeking to implement 340B rebate models.
A national hospital trade group urged federal officials Monday to investigate whether five major drugmakers engaged in anticompetitive practices while [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

South Carolina Congresswoman Honors Health Center and 340B Leader’s Legacy 

U.S. Rep. Sheri Biggs (R-S.C.) touted Sue Veer’s (above) “remarkable career and dedicated leadership” as the president and CEO of Carolina Health Centers in Sept. 4 Congressional Record remarks.
A South Carolina Republican U.S. House lawmaker recently honored the life and legacy of Sue Veer, a nationally recognized leader [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Roundup: Updates in Vermont, Oklahoma, Colorado, Rhode Island

Key briefs were filed recently in litigation over state 340B contract pharmacy laws in Vermont, Oklahoma, Colorado and Rhode Island.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

PhRMA Targets 340B Hospitals in Reported ‘Seven Figure’ Ad Campaign—Its ‘Biggest’ 340B Ad Expenditure Yet

PhRMA released a 30-second television spot targeting the 340B program as part of a reported seven-figure campaign that will run in the Washington D.C.-area through the end of 2025.
Washington D.C.’s most powerful drug industry trade group this week ramped up its attacks on the 340B program, launching what’s [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Mitsubishi Tanabe Pharma Latest Drugmaker to Place 340B Contract Pharmacy Restrictions, Others Add New Drugs, State Exemptions

Mitsubishi Tanabe Pharma America became the 39th drugmaker to enact 340B contract pharmacy restrictions.
A New Jersey-based pharmaceutical manufacturer recently became the 39th drugmaker to enact 340B contract pharmacy restrictions.  Mitsubishi Tanabe Pharma America [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Lobbying Remained Strong in the Second Quarter of 2025, Filings Show

340B program stakeholders continued to spend big on federal lobbying efforts in the second quarter of 2025.
The 340B program continued to garner strong lobbying attention on Capitol Hill this spring, despite Congress’ focus on a GOP-backed [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Six Drugmakers to Refund 340B Covered Entities for Overcharges

Six drugmakers recently announced refunds to 340B covered entities that purchased certain medications between 2019 and 2025.
Several drugmakers recently announced refunds to 340B covered entities that purchased certain medications between 2019 and 2025, following recalculations of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Lilly Looks to Align U.S. Drug Prices with Other Nations Under Trump’s MFN Plan, Cites 340B ‘Abuse’ as Factor in Higher Costs 

Eli Lilly recently announced it’s working on certain pharmaceutical pricing changes to comply with President Donald Trump’s "most-favored nation" executive order.
An Indiana-based pharmaceutical giant recently announced that it’s working to align its U.S. drug prices with those paid by other [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Novartis Exempts South Dakota, Colorado from 340B Contract Pharmacy Restrictions

Novartis recently exempted North Dakota and Colorado from its 340B contract pharmacy restrictions.
A Swiss pharmaceutical giant this week announced new 340B contract pharmacy restriction exemptions for two states that recently enacted contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live